This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Life Sciences Accounting & Reporting Congress
March 18-20, 2025
Hilton at Penn's LandingPhiladelphia, PA

Andrew Zacher
Senior Director, Regulator & Public Policy at Amneal Pharmaceuticals
Speaker

Profile

With over 13 years of experience in government service, including serving as Deputy Chief of Staff and Chief of Staff of the FDA and FDA Detailee to the Senate Health, Education, Labor, and Pensions (HELP) Committee, Andrew Zacher offers unique insight into the inner workings of FDA, HHS, and Capitol Hill as he has helped clients and stakeholders navigate the complex FDA regulatory landscape. During his tenure at the FDA, Andrew held various positions advising senior officials on legal, regulatory, enforcement, and policy matters. As Deputy Chief of Staff and Chief of Staff, Andrew provided strategic direction to senior leadership to manage the agency’s response to public health crises and advance the FDA’s policy priorities. He worked closely with the leadership of all FDA product centers and field operations to support implementation of agency policies and served as the Commissioner’s direct liaison to other executive agencies and organizations on critical public health initiatives. Before joining Amneal as Senior Director, Regulator & Public Policy, Andrew served as FDA Counsel in the D.C. offices of two international law firms.

Agenda Sessions

  • Political Landscape and its Impact on Pharma

    11:45am